Under the terms of the latest agreement, CDR-Life could receive up to up to $570m in total payments. This includes ...
The drug candidate has been given breakthrough and priority medicines designations from the FDA and EMA respectively ...
Branded or unbranded? In clinical marketing, this choice shapes how your message lands. Learn how to pick the right strategy ...
Platelet functionality analysis could pave the way to improving drug asset selection and de-risking clinical trials ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback